Medeor Therapeutics (formerly known as SERC) is a company engaged in the research, development, and commercialization of transformative and personalized cellular immunotherapies. It aims to help transplant patients and people living with immune and hematological diseases. The company combines donor and recipient cells to create mixed chimerism within the transplant recipient.